Antioxidant Therapeutics for Schizophrenia

Antioxidants, Redox Signaling, and Pathophysiology in Schizophrenia: An Integrative View

(2010) Jeffrey K. Yao et al.   ANTIOXIDANTS & REDOX SIGNALING

Mechanisms of n-3 fatty acid-mediated development and maintenance of learning memory performance

(2010) Hui-Min Su   JOURNAL OF NUTRITIONAL BIOCHEMISTRY

Evaluation of antioxidant enzymes activities and lipid peroxidation in schizophrenic patients treated with typical and atypical antipsychotics

(2010) Manuela Padurariu et al.   NEUROSCIENCE LETTERS

Inhibitory effects of polyphenol compounds on lipid peroxidation caused by antipsychotics (haloperidol and amisulpride) in human plasmain vitro

(2010) Anna Dietrich-muszalska et al.   WORLD JOURNAL OF BIOLOGICAL PSYCHIATRY

Clozapine protects PC-12 cells from death due to oxidative stress induced by hydrogen peroxide via a cell-type specific mechanism involving inhibition of extracellular signal-regulated kinase phosphorylation

(2009) Brian C. Magliaro et al.   BRAIN RESEARCH

Review and meta-analysis of usage of ginkgo as an adjunct therapy in chronic schizophrenia

(2009) Vidhi Singh et al.   INTERNATIONAL JOURNAL OF NEUROPSYCHOPHARMACOLOGY

A Preliminary Investigation of α-Lipoic Acid Treatment of Antipsychotic Drug-Induced Weight Gain in Patients With Schizophrenia

(2009) Eosu Kim et al.   JOURNAL OF CLINICAL PSYCHOPHARMACOLOGY

Comparing the Effects of High-Dose Vitamin E With Those of Placebo on Insulin Resistance in Patients With Schizophrenia Treated With Olanzapine

(2009) Fiona Baroyant Salmasi et al.   JOURNAL OF CLINICAL PSYCHOPHARMACOLOGY

Naturally occurring phytochemicals for the prevention of Alzheimer’s disease

(2009) Jiyoung Kim et al.   JOURNAL OF NEUROCHEMISTRY

Position of the American Dietetic Association: Nutrient Supplementation

(2009)   JOURNAL OF THE AMERICAN DIETETIC ASSOCIATION

Potential Effect of Olanzapine on Total Antioxidant Status and Lipid Peroxidation in Schizophrenic Patients

(2009) Basil M. Al-chalabi et al.   NEUROPSYCHOBIOLOGY

Ethyl-Eicosapentaenoic Acid in First-Episode Psychosis. A 1H-MRS Study

(2008) Gregor E Berger et al.   NEUROPSYCHOPHARMACOLOGY

Negative Correlation between Brain Glutathione Level and Negative Symptoms in Schizophrenia: A 3T 1H-MRS Study

(2008) Daisuke Matsuzawa et al.   PLoS One